Cantabio Pharmaceuticals Inc.
company.status.inactiveCIK 1550518fmd_0J163HF0QJRYTVPQ651QT4WWS6Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Apr 01, 2012 to Dec 31, 2018, 27 periods
Latest annual · FY2014
Millions- Total revenues
- 0
- Operating income
- (0)
- Net income
- (2)
Latest quarter · Q3 FY2019
Millions- Net income
- 0
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2013 to FY2018
- n/m
Cantabio Pharmaceuticals Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2018 | FY2017 | Change | Source |
|---|---|---|---|---|
| Net income | -$2 million | -$1.1 million | 10-K 2018-07-16 · proof | |
| Cash from operating activities | -$623,349 | -$973,120 | 10-K 2018-07-16 · proof | |
| Total assets | $109,426 | $33,523 | +226.4% | 10-K 2018-07-16 · proof |
| Total liabilities | $2 million | $887,445 | +123.4% | 10-K 2018-07-16 · proof |
| Cash and cash equivalents | $109,426 | $32,275 | +239% | 10-K 2018-07-16 · proof |
- What was Cantabio Pharmaceuticals Inc.'s net income in fiscal 2018?
- Cantabio Pharmaceuticals Inc. reported net income of -$2 million for fiscal 2018 (the year ended Mar 31, 2018), against -$1.1 million the year before. Source: the 10-K filed with the SEC on Jul 16, 2018. SEC
- What was Cantabio Pharmaceuticals Inc.'s cash from operating activities in fiscal 2018?
- Cantabio Pharmaceuticals Inc. reported cash from operating activities of -$623,349 for fiscal 2018 (the year ended Mar 31, 2018), against -$973,120 the year before. Source: the 10-K filed with the SEC on Jul 16, 2018. SEC
- What are Cantabio Pharmaceuticals Inc.'s total assets?
- As of Mar 31, 2018, Cantabio Pharmaceuticals Inc. reported total assets of $109,426, against $33,523 a year earlier (+226.4%). Source: the 10-K filed with the SEC on Jul 16, 2018. SEC
- What are Cantabio Pharmaceuticals Inc.'s total liabilities?
- As of Mar 31, 2018, Cantabio Pharmaceuticals Inc. reported total liabilities of $2 million, against $887,445 a year earlier (+123.4%). Source: the 10-K filed with the SEC on Jul 16, 2018. SEC
- What are Cantabio Pharmaceuticals Inc.'s cash and cash equivalents?
- As of Mar 31, 2018, Cantabio Pharmaceuticals Inc. reported cash and cash equivalents of $109,426, against $32,275 a year earlier (+239%). Source: the 10-K filed with the SEC on Jul 16, 2018. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1550518&period_type=annual&limit=5"Information only, not investment advice.